We are live on ! Find out more
PIP

Palisades Investment Partners Portfolio holdings

AUM $352M
1-Year Est. Return 76.79%
This Fund
S&P 500
This Quarter Est. Return
+12.65%
1 Year Est. Return
+76.79%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$255M
AUM Growth
+$25.9M
Cap. Flow
+$8.53M
Cap. Flow %
3.35%
Top 10 Hldgs %
48.61%
Holding
51
New
12
Increased
30
Reduced
5
Closed
2

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$9.28M
2
ROOT icon
Root
ROOT
+$8.56M
3
PAYS icon
Paysign
PAYS
+$5.74M
4
PKE icon
Park Aerospace
PKE
+$5.26M
5
IESC icon
IES Holdings
IESC
+$4.58M

Sector Composition

Rank Sector Weight
1 Industrials 37.89%
2 Technology 19.97%
3 Healthcare 18.34%
4 Financials 13.37%
5 Consumer Discretionary 4.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STRL icon
1
Sterling Infrastructure
STRL
$16.7B
$32.5M 12.78%
95,800
-2,928
-3% -$831K
SPXC icon
2
SPX Corp
SPXC
$10.8B
$21M 8.25%
112,439
+1,431
+1% +$264K
MMYT icon
3
MakeMyTrip
MMYT
$5.64B
$11M 4.32%
117,464
+741
+0.6% +$72K
IWM icon
4
iShares Russell 2000 ETF
IWM
$83B
$9.78M 3.84%
+40,433
New +$9.28M
ITRI icon
5
Itron
ITRI
$4.54B
$9.17M 3.6%
73,647
+84
+0.1% +$10.7K
WGS icon
6
GeneDx Holdings
WGS
$2.3B
$9.13M 3.58%
84,743
+1,768
+2% +$193K
AMSC icon
7
American Superconductor
AMSC
$1.59B
$8.38M 3.29%
141,109
+611
+0.4% +$30.5K
MEDP icon
8
Medpace
MEDP
$16.5B
$8.17M 3.21%
15,892
+135
+0.9% +$58.9K
ROOT icon
9
Root
ROOT
$798M
$7.31M 2.87%
+81,716
New +$8.56M
KRYS icon
10
Krystal Biotech
KRYS
$9.66B
$7.31M 2.87%
41,389
+1,186
+3% +$178K
UFPT icon
11
UFP Technologies
UFPT
$2.43B
$6.92M 2.72%
34,660
+157
+0.5% +$34.5K
INTA icon
12
Intapp
INTA
$2.91B
$6.75M 2.65%
165,053
+994
+0.6% +$43K
CRMD icon
13
CorMedix
CRMD
$584M
$6.56M 2.58%
564,106
+1,579
+0.3% +$19.1K
ENVA icon
14
Enova International
ENVA
$6.29B
$6.29M 2.47%
54,619
+144
+0.3% +$16.5K
BMI icon
15
Badger Meter
BMI
$4.03B
$6.1M 2.4%
34,186
+517
+2% +$102K
MWA icon
16
Mueller Water Products
MWA
$4.17B
$6.03M 2.37%
236,456
+1,058
+0.4% +$27K
PAY icon
17
Paymentus
PAY
$4.86B
$6M 2.35%
195,998
+962
+0.5% +$31.8K
PKE icon
18
Park Aerospace
PKE
$819M
$5.9M 2.32%
+290,253
New +$5.26M
PAYS icon
19
Paysign
PAYS
$698M
$5.65M 2.22%
+897,634
New +$5.74M
MC icon
20
Moelis & Co
MC
$4.94B
$5.44M 2.14%
76,337
+335
+0.4% +$23.9K
VCYT icon
21
Veracyte
VCYT
$3.8B
$5.43M 2.13%
158,143
-4,265
-3% -$122K
IESC icon
22
IES Holdings
IESC
$15.2B
$5.29M 2.08%
+13,314
New +$4.58M
SPSC icon
23
SPS Commerce
SPSC
$2.64B
$5.12M 2.01%
49,137
+224
+0.5% +$26.7K
LUNR icon
24
Intuitive Machines
LUNR
$2.63B
$4.19M 1.65%
398,571
+7,331
+2% +$74.3K
FFBC icon
25
First Financial Bancorp
FFBC
$3.53B
$3.78M 1.49%
149,854
+656
+0.4% +$16.6K

Similar funds

Palisades Investment Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Palisades Investment Partners held 51 positions worth $255M, up 11% from $229M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Palisades Investment Partners deployed $8.53M of net new capital in Q3 2025, opening 12 new positions and adding to 30 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 40,433 shares worth $9.78M.

By sector, the portfolio is most concentrated in Industrials at 38% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Innodata, an estimated $18.2M trimmed.

  • Palisades Investment Partners's largest Q3 2025 buy was iShares Russell 2000 ETF: 40,433 shares worth $9.78M.
  • Palisades Investment Partners added most to SPX Corp in Q3 2025, an estimated $264K increase.
  • Palisades Investment Partners's biggest Q3 2025 reduction was Innodata, cutting an estimated $18.2M.
  • Palisades Investment Partners fully exited ADMA Biologics in Q3 2025, selling an estimated $7.26M.
  • Palisades Investment Partners's ten largest holdings make up 49% of its $255M portfolio in Q3 2025.
  • Palisades Investment Partners opened 12 new positions and closed 2 in Q3 2025.
  • Palisades Investment Partners's portfolio value rose 11% quarter-over-quarter to $255M.

Based on Palisades Investment Partners's 13F filing for Q3 2025, filed 30 Oct 2025.